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vious year, and any history of reactions to products that may 
contain the sensitizer and/or a history of avoidance of the 
same products. Patch test data are linked to the question-
naire information to define clinical relevance.  Results: The 
questionnaire showed high test-retest reliability in 94 indi-
viduals. Patch test reading also showed a high level of inter-
rater reliability. During the pilot phase, a total of 589 partici-
pants were recruited.  Conclusions: The EDEN Fragrance 
Study is feasible and able to provide useful data on fragrance 
allergy.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 The existing data on the prevalence of allergies from 
contact with fragrances in the general population are 
very limited  [1] . Data originating from allergological ser-
vices concerning what is known as the ‘patch test popula-
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 Abstract 
 Background/Aims: Data on contact allergy to fragrances in 
the general population are limited. Data from allergological 
services suggest that the frequency of contact allergy to fra-
grances is increasing. The European Dermato-Epidemiology 
Network (EDEN) Fragrance Study aims to obtain reliable data 
on the prevalence of contact allergy to fragrances and other 
sensitizers of the European baseline series, in the general 
population of different geographical areas of Europe. We re-
port the methodology and the reliability of instruments
adopted and discuss the feasibility based on a pilot phase. 
 Methods: Descriptive epidemiology survey. A random sam-
ple from the general population is selected and interviewed, 
and is offered patch testing in a randomized way. We spe-
cifically enquire about any skin rash reported during the pre-
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tion’ suggest that the frequency of allergies to fragrances 
is continuously increasing  [2, 3] . Given the widespread 
use of substances containing fragrances (e.g. detergents, 
shampoos, deodorants) in the general population, this in-
crease may be relevant to public health. 
 Epidemiology can contribute crucially to evaluating 
the importance of allergy to fragrances by estimating the 
frequency of the disease in the general population and/or 
subgroups and by assessing the role of potential risk fac-
tors. The lack of standardization in the studies conducted 
so far limits the validity of spatial and temporal compar-
isons  [4] . In groups of unselected individuals, the fre-
quency of positive patch test reactions to fragrances has 
been estimated at around 1.1% in a study from Denmark 
 [5] and 1.8% in a study from Norway  [6] . 
 The European Dermato-Epidemiology Network 
(EDEN) has designed the ‘EDEN International Study on 
the Prevalence of Contact Allergy to Fragrances’ (EDEN 
Fragrance Study)  [1, 3] , which aims to obtain reliable data 
on the prevalence of contact allergy to fragrances in the 
general population in different geographical areas. By us-
ing standardized study methods, the project goal is to 
finally provide useful data for public health. Here we re-
port the methodology and the reliability of instruments 
adopted in our study and discuss the feasibility based on 
our experience in the pilot clinical phase.
 Materials and Methods 
 Design of the Study 
 The EDEN Fragrance Study is a descriptive epidemiology sur-
vey. A random sample from the general population is invited to 
answer a questionnaire and offered patch testing in a randomized 
way.  Figure 1 shows the study design, which yields two sets of in-
formation:  (1) by a questionnaire, (a) any history of clinically rel-
evant skin reactions independent of the nature of the reaction, 
during the month and/or the year preceding the interview, (b) any 
history of skin reactions to products commonly containing the 
allergens of interest and (c) any history of avoidance of such prod-
ucts because of a skin reaction at any time during the person’s 
lifetime;  (2) by patch testing, any positive skin reaction to tested 
allergens.  In addition to estimates of positive reaction prevalence, 
we can also obtain estimates of the prevalence of clinically rele-
vant reactions to fragrances (or to other substances of interest) by 
combining the above information for a randomly chosen subsam-
ple undergoing patch testing. In this study, a clinically relevant 
reaction is considered to be any skin rash reported during the pre-
vious month and/or the previous year, associated with a positive 
patch test reaction to a contact sensitizer and with a previous his-
tory of reactions to products that may contain the sensitizer and/
or a history of avoidance of the same products.
 Sampling Strategy 
 The EDEN Fragrance Study is an international and multicen-
tric study that involves various geographic areas in 5 European 
countries: Germany, Italy, The Netherlands, Portugal and Sweden 
( fig. 2 ). In each area, a random population sample is recruited. 
 In Germany, 2 different geographical areas are included: the 
province of Thüringen, with Jena and Apolda, and the province 
of Baden-Württemberg, including Heidelberg. In the Nether-
lands, areas are the province of Groningen with the city of Gro-
ningen and the municipality of Stadskanaal. In Italy, the province 
of Bergamo is sampled with the city of Bergamo and its 15 mu-
nicipalities, and the towns of Treviglio and Caravaggio. The in-
cluded area in Portugal is the district of Coimbra with the city of 
Coimbra. In Sweden, the province of Skåne is targeted, including 
the city of Malmö ( fig. 2 ). 
Overall sampling procedure
AND
Questionnaire: A history 
of itchy skin rash in 
the previous month or
previous 12 months
Subsample randomly chosen




of products and/or lifetime
history of previous reactions
to products
 Fig. 1. Schematic representation of the de-















 Fig. 2. Geographical areas where each centre will perform a sam-
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 To obtain a representative sample of the population within 
each geographical area, we are using a stratified proportional 
sampling design with replacement. In the sampling plan, the dis-
tribution of the population by age, gender and geographical loca-
tion are accounted for. The final sample is expected to be well 
balanced in terms of the main demographic variables and repre-
sentative of the final target population for these variables. All in-
dividuals aged 18–74 years are eligible. We are also using the same 
stratified proportional sampling design with replacement to ob-
tain the subsample of participants to whom we will offer patch 
testing. 
 Recruitment Procedures  
 We are contacting by letter participants selected through the 
sampling procedure. A second letter and a phone call follow in 
case of non-response. Sampled individuals are asked to send back 
a reply prestamped card to accept or refuse participation in the 
study. Participants, who are free to withdraw from the study at 
any time, receive more detailed information by e-mail or by 
phone, and an operator contacts them to set a date for a face-to-
face interview conducted at home or at a hospital. Participants 
also selected to undergo patch testing are asked to set a date for 
application, removal and reading of the patch test. Specialized 
and trained nurses apply and remove patches at the individual 
homes of participants in the Netherlands and in Italy, and in the 
hospital in the other countries; expert dermatologists in the hos-
pitals do the readings.
 Questionnaire 
 The questionnaire consists of 3 parts. The demographic part 
gathers general information on age, gender, ethnic group, occupa-
tion and marital status. The section on medical history focuses on 
history of skin problems characterized by localized erythema and 
itching lasting for more than 3 days during the past year and the 
past month. Other information collected includes any previous 
dermatological diagnoses, with a special focus on contact derma-
titis, and any allergy test carried out. The history of exposure to 
products containing fragrances focuses on the frequency with 
which the participant uses certain products, characterized by 
their fragrance content. This part also records any possible prob-
lem related to a skin contact with these products. Questions on 
the use of topical medications are also included. In each country, 
trained interviewers conduct the interviews, using the relevant 
language questionnaire (derived from the English version by the 
translation/backtranslation technique).
 In 2005, we undertook a study to estimate reproducibility of 
the questionnaire. This study involved comparison of the results 
for 60 items from the questionnaire, which was administered 
twice at an interval of 1–8 weeks (median = 1 week) to 94 volun-
teers (31 males and 64 females, median age = 40 years) from 3 
European regions: Italy (Bergamo, 40 people), The Netherlands 
(Groningen, 34 people) and Sweden (Malmö, 21 people). 
 Patch Tests 
 Patch testing is performed according to the International Con-
tact Dermatitis Research Group guidelines. Weak (+), strong (++) 
and extreme (+++) reactions with an allergic morphology are con-
sidered as positive reactions. Both thin-layer rapid-use epicutane-
ous (TRUE) test and Finn chambers  are used, testing for a total 
of 47 allergens. TRUE test standard series include panel 1, panel 
2 and panel 3 containing 29 allergens. In Finn chambers, we test 
as petrolatum preparations fragrance mix 1, fragrance mix 2, 
their 14 individual fragrance allergens and the emulsifier sorbitan 
sesquioleate in fragrance mix 1 as well as sesquiterpene lactone 
mix. This testing using TRUE test panels and petrolatum prepa-
rations tests for all contact sensitizers in the European baseline 
series except primin and methyldibromoglutaronitrile  [7] .
 Two courses have been held at the Department of Occupation-
al and Environmental Dermatology at the University Hospital in 
Malmö to improve the patch test procedure by standardizing the 
application of a defined amount of the petrolatum preparation on 
a Finn chamber and reading of the patch test. Twelve specialized 
nurses from all participating centres were taught and practiced 
applying the amount of petrolatum preparation recommended by 
the European Society of Contact Dermatitis for application onto 
a Finn chamber  [8] .
 The second course focused on standardizing the patch test 
reading. After approval of the Ethical Committee, 11 dermatolo-
gists from the participating centres took part in this study at the 
Department of Occupational and Environmental Dermatology in 
Malmö. The dermatologists were not informed about the study 
until the morning when the patch test reading took place. They 
were told that 6 patients with suspected allergic contact dermati-
tis had been patch tested 3 days earlier with sensitizers from the 
baseline test series and supplemented with other chemicals from 
their own environment. Dermatologists performed the scoring 
independently and without communication with the patients or 
among themselves. 
 Six patients with known contact allergies within the groups of 
fragrances, metals and preservatives as well as 2 well-known ir-
ritants were patch tested. Every patient was patch tested with dilu-
tions of the sensitizers and irritants to ascertain that allergic and 
irritant reactions were obtained of various strengths, including 
negative, doubtful and positive reactions. The application of the 
Finn chambers with the test preparations onto the individual 
backs of the 6 patients was randomized. 
 After the initial reading, there was a lecture on patch test read-
ing based on the International Contact Dermatitis Research 
Group classification and with emphasis on the distinction among 
irritant, doubtful and allergic reactions as well as the require-
ments for grading into the different allergic groups (+, ++, +++). 
 Following the lecture, the dermatologists performed a second 
reading of the patient findings. We then evaluated the agreement 
of the readings before and after the lecture, using as the gold stan-
dard the answers from an expert dermatologist from the Depart-
ment of Occupational and Environmental Dermatology. 
 Data Collection and Monitoring 
 The study group developed a Web-based electronic form to 
collect data from the questionnaire and from patch testing. Cross-
reference checks in the electronic form enable reduction of
input errors, missing data and inconsistencies. To improve stan-
dardization, the group also developed a video presentation for
the study, which is available for download at http://area-lavoro.
centrostudigised.it/EDEN_Fragrance_Study/Patch_Test_film.
wmv. 
 Study Pilot Phase 
 The pilot phase of the study took place between January 2006 
and August 2007. During this phase, each national team applied 
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the study methods as indicated above with the exception of adopt-
ing a simple randomization plan for recruiting the sample of 100 
people. Preliminary estimates of the prevalence of contact allergy 
to fragrances were obtained to calculate the final sample size and 
to optimize the study design. 
 Sample Size 
 Using data from the pilot clinical phase, we estimated that the 
1-year prevalence of a clinically relevant reaction to fragrances 
was not lower than 1%. Based on this estimate, we performed a 
power analysis to identify the cut-off for adequate power to inves-
tigate the prevalence of contact allergy to fragrances and to docu-
ment possible differences among countries. Using the exact 
(Clopper-Pearson) confidence interval method  [9] , we estimated 
that a sample size of 3,000 produces a 2-sided 95% confidence in-
terval with a width equal to 0.08 and a relative standard error of 
17% when the sample prevalence is 1.00% (95% confidence iner-
val, 0.06–1.40%;  fig. 3 ). We thus require a sample of 500 individu-
als interviewed and patch tested per centre, for a total of 3,000 
individuals. We further sample about 1,500 individuals for the 
interviews per centre (a total of a further 12,000 individuals in-
terviewed). 
 Data Analyses 
 To assess agreement in the reproducibility studies, we calcu-
lated Cohen’s kappa coefficient for categorical items and the in-
traclass correlation coefficient for quantitative data. Values from 
0.41 to 0.60 indicate moderate agreement, values from 0.61 to 0.80 
substantial agreement, and values from 0.81 to 1.00 almost perfect 
agreement.
 We calculate weighted estimates of the prevalence of positive 
reactions to allergens and of clinically relevant reactions to aller-
gens, taking into account the age and gender distribution of the 
population in the different geographical areas. To estimate pos-
sible selection biases in the selection of the subsample, we com-
pare the characteristics (obtained by the questionnaire) of indi-
viduals undergoing the interview with those of the subsample also 
undergoing patch testing.
 Finally, we calculate the prevalence of contact allergies overall 
and in different geographical areas and assessed geographical 
variations and potential risk factors. Control for confounding fac-
tors requires standardization procedures and appropriate multi-
variate analysis methods (e.g. logistic regression analysis). 
 All participant centres got approval for the study from their 
ethical committees.
 Results 
 Reliability of Study Methods 
 A high level of agreement emerged for all questions as-
sessed in the interview ( fig. 4 ). Cohen’s kappa statistics 
were 0.85–1 for demographic data and around 0.70 for the 
questions referring to skin problems, previous clinical 
examinations, allergic tests performed, dry skin and sen-
sitive skin. Data concerning the history of skin diseases 
were too limited to calculate the kappa statistic, while the 
agreement for the question concerning itchy skin rash 
was rather low initially (around 0.30). This low agreement 
prompted a change in the code book for collecting data, 
which resulted in a much higher value of the coefficient 
(around 0.70) on a subsequent reliability exercise. The 
weighted kappa statistic for the questions concerning ex-
posure frequencies to selected products containing fra-
grances ranged from 0.54 (‘shampoos’) to 0.91 (‘cosmetic 
product’), with the majority of items yielding kappa val-
ues higher than 0.70. 
 In the course on the standardization of the patch test 
procedure held in Malmö, the application of the recom-
mended amount of petrolatum preparation on a Finn 
chamber was highly satisfactory after the training ses-
sion. Education yielded improvement in patch test read-
ing, but work remains to be done to standardize the read-
ing for weak positive reactions and irritative reactions. 
 Pilot Study Phase 
 During the pilot phase, a total of 589 participants were 
recruited by a simple randomization procedure and in-
terviewed in the centres involved in the study from De-
cember 2006 to May 2007 (from June to August 2007 in 
the Portuguese centre;  table 1 ). There were 117 partici-
pants from Italy, 106 and 101 from the 2 German centres, 
104 from the Netherlands, 101 from Sweden and 60 from 
Portugal (the lower number in Coimbra arises from the 

















 Fig. 3. The graph illustrates the width of the 95% confidence in-
terval (CI), for estimation of a given proportion (P), based on dif-
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 We obtained participation rates from the Italian (ap-
prox. 50%) and Dutch (20%) centres. Among the reasons 
for non-participation were the fact that the study was too 
time consuming (approx. 38%), fear of being tested (ap-
prox. 24%), unsatisfactory reward for participation and 
the presence of a severe skin disease (7%). In Italy and 
similarly in other countries, about 25% of individuals 
representing ‘potential cases’ who agreed initially to be 
patch tested refused later on to do so (50% changed their 
minds, 29% refused because of schedule incompatibility; 
data not shown).
 Table 2 shows the baseline characteristics of the sam-
ple overall and by centre. Participants were mainly wom-
en (59%), younger than 30 or older than 60 years (59%), 
and married (57%). Half were still working (51%). Distri-
bution of gender, marital status and occupational status 
was similar among all the study centres, except for Hei-
delberg and Portugal. In Heidelberg, 61% of participants 
were younger than 30 years, 50% were still students, and 
only 27% were married, reflecting the distribution of a 
university town. The Portuguese population was mainly 
older (52%) and retired (47%). The Italian sample is char-
acterized by a high portion of participants aged between 
40 and 49 years, while in all the other centres, except Hei-
delberg, the highest percentage of the participants was 
older than 59 years. 
 A total of 364 individuals were patch tested, with 115 
(32%) presenting a positive reaction to at least 1 allergen 
and 28 (8%) to at least 1 fragrance allergen. Overall, 55 






Total 589 364 (61.8)
Italy, Bergamo 117 53 (45.3)
Germany, Jena 106 44 (41.5)
Germany, Heidelberg 101 80 (79.2)
The Netherlands, Groningen 104 104 (100.0)
Sweden, Malmö 101 58 (57.4)
Portugal, Coimbra 60 25 (41.7)
Figures in parentheses are percentages.
Demographic aspects Clinical history Product exposure
Questionnaire
agreements
κ = 0.85–1 κ approx. 0.70 κ = 0.54–0.91
κ = 0.30
κ = 0.84 for perfumes
κ = 0.70 for skin creams
κ = 0.78 for deodorants
κ = 0.84 for hair care products
κ = 0.91 for cosmetic products
κ = 0.80 for hygiene products
κ = 0.76 for metals
κ = 0.64 for laundry detergents
κ = 0.78 for dishwashing detergents
κ = 0.70 restricted to last 
20 interviews performed 
with the last version of the 
code book
- Skin problems
- Previous clinical examinations
- Allergic tests performed
- Dry and sensitive skin
- Itchy skin rash lasting >3 days 
  during the last year
- Itchy skin rash lasting >3 days
  during the last month
Questionnaire
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(15%) were positive to nickel with the highest frequencies 
in the Netherlands (22 subjects; 21%) and Italy (13 indi-
viduals; 25%; data not shown).
 Discussion 
 The results of the pilot phase suggest that the EDEN 
Fragrance Study is feasible. In spite of some limitations 
mainly arising from differences with data collection 
among the centres, the study on the reproducibility of the 
questionnaire showed a good level of reproducibility. 
 Patch testing procedures showed a high level of repro-
ducibility concerning the preparation phase. With regard 
to patch test reading, the need for better standardization 
of readings became obvious even though all readers were 
already supposed to be using the same classification sys-
tem when reading the patient findings initially. However, 
the general consensus is that patch testing is fairly reliable 
when the same patch test material is used  [10] . 
 Although the pilot study is important for optimizing 
methodology based on experience  [3] , the results of this 
pilot study phase should not be overinterpreted. Because 
of the limited size of the sample to be collected, the study 
group adopted a simple randomization procedure so that 
the sample obtained was not necessarily fully representa-
tive of the target population. Moreover, the short study 
duration did not allow for arranging a suitable time for 
patch testing for a number of sampled individuals who, 
in principle, were willing to participate but were not 
available for patch testing on the proposed dates. The full 
study phase will last much longer. 
 Recently, a systematic review of studies on contact sen-
sitization to fragrances in the general population found 
13 studies performed among adults  [10] . Sample size var-
ied between 82 and 2,545 tested individuals, for a total of 
11,648 tested. Based on these studies, the weighted aver-
age prevalence of fragrance mix 1 was 3.7%. The major 
limitations of that study are those that are typical of a 
meta-analysis study  [11] , and also include the exclusion of 
fragrance mix 2 from the investigation. In fact, to our 
knowledge, no previous studies have investigated the 
prevalence of fragrance mix 2 sensitization in the general 
population. The frequency of contact sensitization to fra-



















Male 53 (45.3) 53 (50.0) 37 (36.6) 42 (40.4) 43 (42.6) 15 (25.0) 243 (41.3)
Female 64 (54.7) 53 (50.0) 64 (63.3) 62 (59.6) 58 (57.4) 45 (75.0) 346 (58.7)
Age group
18–29 years 17 (14.5) 25 (23.6) 62 (61.4) 15 (14.4) 11 (10.9) 8 (13.3) 138 (23.4)
30–39 years 29 (24.8) 12 (11.3) 13 (12.9) 17 (16.4) 16 (15.8) 3 (5.0) 90 (15.3)
40–49 years 35 (29.9) 19 (17.9) 11 (10.9) 17 (16.4) 23 (22.8) 11 (18.3) 116 (19.7)
50–59 years 18 (15.4) 20 (18.9) 5 (4.9) 25 (24.0) 18 (17.8) 7 (11.7) 93 (15.8)
60–75 years 18 (15.4) 30 (28.3) 10 (9.9) 30 (28.9) 33 (32.7) 31 (51.7) 152 (25.8)
Marital status
Married 83 (70.9) 63 (59.4) 27 (26.7) 62 (59.6) 74 (73.3) 29 (48.3) 337 (57.2)
Unmarried 28 (24.0) 34 (32.1) 71 (70.3) 32 (30.8) 19 (18.8) 17 (28.3) 202 (34.3)
Divorced/widowed 4 (4.3) 9 (8.5) 3 (3.0) 9 (8.7) 8 (7.9) 14 (23.3) 48 (8.1)
Missing 1 (0.8) – – 1 (0.9) – – 2 (0.3)
Occupational status
Working 73 (62.4) 48 (45.3) 31 (30.7) 52 (50.0) 68 (67.3) 24 (40.0) 272 (51.4)
Student 6 (5.1) 16 (15.1) 51 (50.5) 10 (9.6) 5 (5.0) 6 (10.0) 88 (16.6)
Unemployed 1 (0.9) 10 (9.4) 5 (4.9) 4 (3.9) 1 (1.0) – 21 (4.0)
Retired 16 (13.7) 22 (20.8) 7 (6.9) 20 (19.2) 24 (23.8) 28 (46.7) 89 (16.8)
Homemaker 19 (16.2) 3 (2.8) 3 (2.9) 15 (14.4) 1 (1.0) 2 (3.3) 41 (7.8)
Other 2 (1.7) 7 (6.6) 4 (3.9) 3 (2.9) 2 (2.0) – 18 (3.4)
F igures in parentheses are percentages.
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grances strictly depends on the number of allergens test-
ed, and patch testing with fragrance mix 2 detects addi-
tional patients sensitive to perfumes and missed by fra-
grance mix 1 testing  [7, 12, 13] ; thus, we would expect that 
the overall prevalence of contact sensitization to fra-
grances would be higher than prevalence estimates so far. 
This inclusion could account, at least in part, for the rel-
atively high frequency of contact sensitization to fra-
grances we found in the pilot investigation. However, 
more data from the general population, such as those we 
will collect during the full phase of the study in selected 
regions of Europe, are needed to obtain more reliable and 
valid estimates of the prevalence of contact sensitization 
to fragrances in line with the new regulations concerning 
the use of fragrances in commercial products  [7, 14] . 
These data will provide relevant information to the Eu-
ropean Union Cosmetics Directive 76/768/EEC, which 
has been amended more than 50 times. Furthermore, 
they will allow reduction of misleading results in which 
the contact allergy was found to be responsible only for a 
minority of all reactions to cosmetics and toiletries on 
sale  [15] . They are also expected to reduce the frequency 
of situations in which the concentration of allergens in 
perfume products was much higher than the maximum 
tolerable concentration considered safe by the EU Scien-
tific Committee  [16] . Postmarketing surveillance studies 
are also required to integrate and compare different 
sources of data and to establish safety  [17] . 
 Further difficulties in establishing estimates of con-
tact sensitizations to fragrances are related to the vari-
ability in the concentrations of allergens in solution (or 
petrolatum)  [12, 18] . Moreover, one controversial issue is 
the reliability of reactions to a fragrance mix  [18–20] . On 
one hand, a fragrance mix represents recognized fra-
grance materials; on the other hand, there are concerns 
that positive reactions to the fragrance mix really reflect 
contact sensitization to individual constituents. Studies 
suggest that positive reactions to the fragrance mix do not 
guarantee that one or more of its components will give 
reactions in subsequent or concomitant patch tests  [18] . 
It has been suggested that allergens in combination have 
a synergistic effect on the elicitation response  [21] . Our 
study will allow estimation of the correlation between a 
positive reaction to a fragrance mix and to single aller-
gens for both fragrance mix 1 and fragrance mix 2. More-
over, because our study uses two tests, the TRUE test and 
the Finn chamber, we will be able to estimate their agree-
ment. Previous studies on this issue are inconsistent; in 
addition, they have limitations in terms of assessing prev-
alence or incidence variations of positive reactions in 
populations defined with some basic characteristic and 
may suffer from the ‘floating numerator’ effect  [18] . Our 
pilot study data, in spite of some limitations, have al-
ready provided relevant results on this issue (data not
presented). 
 A new method based on information about patch test 
sales in a given geographical region has been proposed to 
assess the prevalence of contact allergy in the general 
population  [22] . Although this method may be an inex-
pensive alternative for obtaining reliable estimates, a de-
scriptive epidemiological survey in which participants 
represent the general population of the collecting regions, 
like the EDEN Fragrance Study, is currently the best 
method of estimating changing patterns of contact sensi-
tizations arising from environmental pressure and also of 
discovering new associations and risk factors  [10] . We 
will be able to perform cross-analyses on patch test re-
sults and general participant characteristics, including 
skin medical history and frequency of exposure to fra-
grance-containing products, as well as any possible prob-
lem related to skin contact with these products. In par-
ticular, the pilot study phase allowed the construction of 
an algorithm for the standardized assessment of the clin-
ical relevance of positive reactions, based on the ques-
tionnaire. The algorithm results provided an unambigu-
ous case definition, a major requirement in any epide-
miological study  [18] , and the instruments to investigate 
how a positive reaction correlates with clinically relevant 
manifestations  [18] . 
 Of course, ultimately any algorithm for the standard-
ized assessment of the clinical relevance of a positive re-
action based on the questionnaire should be validated. 
Such validation can be achieved with randomized and 
controlled repeated open application. Evaluation accord-
ing to anatomical site, modalities of exposure, pattern of 
reaction and disease severity will be made using our 
questionnaire, which showed a satisfactory level of repro-
ducibility, in spite of the difficulties in developing ques-
tionnaires for previous occupational investigations  [23] . 
Estimates will be sex and age adjusted to avoid differ-
ences in prevalence arising from an imbalance of data in 
terms of these variables. Previous studies, for example, 
have reported a higher prevalence of contact allergy to 
fragrances in women and in aged people  [10, 24] . 
 Other strengths of the EDEN Fragrance Study are that 
it is multicentric, thus allowing comparisons within and 
between countries. In addition, the sample size was com-
puted to provide adequate power to the study.
 In conclusion, the EDEN Fragrance Study will fully 
satisfy the needs that previous studies have exposed  [1, 3, 
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10, 18] . The framework we developed in this study, in-
cluding the reproducible questionnaire, the informative 
material, the patch test courses on application and read-
ing, the video on patch test procedures and the clinical 
relevance definition, will provide useful tools for stan-
dardizing methodology for this multicentre and interna-
tional study, as well as for future investigations on contact 
allergies and dermatitis in the general population.
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